University of PittsburghUniversity of Pittsburgh
Startups
TechnologiesStartupsExpress LicensesCollectionsChat with AI
Sign in
University of Pittsburgh

Creegh Pharmaceuticals, Inc.

OverviewRequest InfoMore Like ThisExpress Licenses

Sector

Therapeutics

Therapeutic Areas

RespiratoryNeuroscienceImmunology

Therapeutic Indications

Asthma

Funding Stage

Seed

Founders

Bruce A. FreemanFrancisco J. Schopfer

Website

https://creegh.com/

Creegh Pharmaceuticals is developing medicines inspired by nitroalkenes, naturally occurring molecules that help regulate inflammation, metabolism and cellular stress. Cofounded by Bruce A. Freeman and Francisco J. Schopfer, the Pittsburgh company draws on research connected to the University of Pittsburgh to pursue new approaches to inflammatory and degenerative disease. [1] [2]

Its development portfolio includes programs for obesity-associated asthma and Parkinson’s disease. The platform aims to influence several connected biological pathways, bringing the body’s own signaling mechanisms into the search for new treatment options. [1]

Discover More with AI